Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESGO 2021 | KORE Innovation trial: an enhanced perioperative pathway for patients with ovarian cancer

Jalid Sehouli • 24 Oct 2021
ESGO 2021
Gynecological Cancer Ovarian Cancer
KORE Innovation Trial

Jalid Sehouli, MD, Charité University of Medicine Berlin, Berlin, Germany, discusses the rationale behind the KORE Innovation Trial, a European initiative in patients with gynecological malignancies. This study is an open, prospective, multicentric, interventional study that will implement and evaluate an enhanced perioperative pathway for patients with ovarian cancer. This interview took place at the European Society of Gynaecological Oncology (ESGO) 2021 congress in Prague.

More from Jalid Sehouli

1:54
Updates in gynecological cancers at ESMO 2023
Jalid Sehouli • 21 Oct 2023
2:51
Bringing change with TTFields therapy in ovarian cancer
Jalid Sehouli • 21 Oct 2023
2:22
Endometrail cancer patients: global views on genetic counseling and hereditary carcinomas
Jalid Sehouli • 21 Oct 2023
2:42
Breaking bad news in oncology
Jalid Sehouli • 24 Oct 2021

Related Videos

0:39
Early diagnosis of ovarian cancer with Pap smears
Sergio Marchini • 8 Apr 2024
0:46
FRa expression and sequencing ADCs in endometrial cancer
Rebecca Porter • 8 Apr 2024
4:12
PETRA: saruparib in solid tumors with BRCA1/2, PALB2 or RAD51C/D mutations
Timothy Yap • 7 Apr 2024
1:11
Clonal hematopoiesis mutations in ovarian carcinomas
Rebecca Porter • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals